HPK1-IN-2 is a potent, orally bioavailable small molecule inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1), also inhibiting Lck and Flt3. It demonstrates antitumor activity and is a valuable chemical probe for researching HPK1 signaling in immunology and oncology, applicable in both in vitro and in vivo experimental models.
Molekulargewicht:
380.47
Reinheit:
99.62% (May vary between batches)
CAS Nummer:
[2056122-11-1]
Formel:
C19H20N6OS
Target-Kategorie:
Src,FLT
Anwendungsbeschreibung:
Solubility: H2O:25 mg/mL (65.71 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten